Their data suggest that PD‐L2 has a more predominant role than PD‐L1 in shaping the immune‐tolerogenic environment, given the highly significant association with key pathways involved in innate, adaptive immunity, and inflammation in pheochromocytomas and paragangliomas. This evidence concerns the gene PDCD1LG2 and pheochromocytoma.